NEONC TECHNOLOGIES HOLDINGS, INC. Accounts Payable and Accrued Liabilities, Current
NEONC TECHNOLOGIES HOLDINGS, INC. (NTHI) had Accounts Payable and Accrued Liabilities, Current of $3.44 million as of 2026-06-30, per its 10-Q filed 2026-08-10.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current › Accounts Payable and Accrued Liabilities, Current
us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent · last filed 2026-08-10
- 2026-06-30: Accounts Payable and Accrued Liabilities, Current $3.44M.
- 2026-03-31: Accounts Payable and Accrued Liabilities, Current $2.47M.
- 2025-12-31: Accounts Payable and Accrued Liabilities, Current $2.86M; Accounts Payable and Accrued Liabilities, Current as first filed $6.12M.
- 2025-09-30: Accounts Payable and Accrued Liabilities, Current $1.64M.
| Period end | Accounts Payable and Accrued Liabilities, Current | Accounts Payable and Accrued Liabilities, Current as first filed |
|---|---|---|
| 2026-06-30 | $3.44M 10-Q · filed 2026-08-10 | |
| 2026-03-31 | $2.47M 10-Q · filed 2026-05-15 | |
| 2025-12-31 | $2.86M 10-Q · filed 2026-08-10 | $6.12M 10-K · filed 2026-03-31 |
| 2025-09-30 | $1.64M 10-Q · filed 2025-11-14 | |
| 2024-12-31 | $2.89M 10-K · filed 2026-03-31 | $2.92M 10-Q · filed 2025-11-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ONCOLYTICS BIOTECH INC (ONCY) | $0.086B | ||
| Lexaria Bioscience Corp. (LEXX) | $0.084B | -1.92 | |
| Telomir Pharmaceuticals, Inc. (TELO) | United States | $0.084B | |
| Rallybio Corp (RLYB) | United States | $0.089B | |
| Acrivon Therapeutics, Inc. (ACRV) | United States | $0.091B | -1.03 |
| Gain Therapeutics, Inc. (GANX) | United States | $0.080B | -4.40 |
| Lifevantage Corp (LFVN) | United States | $0.078B | 15.40 |
| Adicet Bio, Inc. (ACET) | United States | $0.078B | -0.81 |
| Valion Bio, Inc. (VBIO) | United States | $0.077B | |
| MAIA Biotechnology, Inc. (MAIA) | United States | $0.077B | -2.30 |